--2024/Q4-- / 182.000K--
--2024/Q3481.830K / 580.000K--
--2024/Q2566.480K / 432.000K--
--2024/Q1408.200K / 513.000K--
--2023/Q4530.400K / 554.000K--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
XBIO Xenetic Biosciences
- 4.2900
- +0.0100+0.23%
Close Dec 20 16:00 ET
6.62MMarket Cap-1.61P/E (TTM)
4.3086High4.1600Low3.61KVolume4.1700Open4.2800Pre Close15.36KTurnover0.31%Turnover RatioLossP/E (Static)1.54MShares5.200052wk High0.94P/B5.05MFloat Cap2.780052wk Low--Dividend TTM1.18MShs Float59399.9505Historical High--Div YieldTTM3.47%Amplitude2.4010Historical Low4.2600Avg Price1Lot Size
Xenetic Biosciences Key Stats
Xenetic Biosciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: GBP
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Xenetic Biosciences Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data